3,5-DIFLUORO-4-(2,2,2-TRIFLUOROETHOXY)BENZALDEHYDE, 97.0%, 1g

(5-Bromo-2-((4-methoxybenzyl)oxy)phenyl)(3,5-dimethoxyphenyl)methanone, 95+%, 250mg

((4-Bromobenzyl)oxy)(tert-butyl)dimethylsilane, 95+%, 1g

(1R,5S)-3-(2H-1,2,3-triazol-2-yl)-8-azabicyclo[3.2.1]octane hydrochloride, 95.0%, 500mg

4-Hydroxy-5-methylpyrimidine, 95.0%, 250mg

2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile, 97.0%, 250mg

Sodium polytungstate hydrate, min. 99.9%, pa, 50 g, plastic packaging.

N-(2-(7-HYDROXYNAPHTHALEN-1-YL)ETHYL)ACETAMIDE, 95%, 5mg

Methyl 4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 5g

Ethyl 4-Bromophenylacetate>98.0%(GC)25g

BENZYL 4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE, 95.0%, 25g

3-Chloro-5-methylbenzoic acid, 98.0%, 25g

1-Bromo-2-chloro-4,6-difluorobenzene, 95.0%, 1g